Global Prostate Cancer Diagnostics Sales Market Report 2023
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Diagnostics Market Size by Type (2018 VS 2022 VS 2029)
1.2.2 Tumor Biomarker Tests
1.2.3 Imaging
1.2.4 Biopsy
1.2.5 Other
1.3 Market by Application
1.3.1 Global Prostate Cancer Diagnostics Market Share by Application (2018 VS 2022 VS 2029)
1.3.2 Age Below 55
1.3.3 Age 55-75
1.3.4 Age Above 75
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Diagnostics Market Perspective (2018-2029)
2.2 Global Prostate Cancer Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
2.3 Global Prostate Cancer Diagnostics Revenue Market Share by Region (2018-2023)
2.4 Global Prostate Cancer Diagnostics Revenue Forecast by Region (2024-2029)
2.5 Geographic Market Analysis: Market Facts & Figures
2.5.1 United States Prostate Cancer Diagnostics Estimates and Projections (2018-2029)
2.5.2 Europe Prostate Cancer Diagnostics Estimates and Projections (2018-2029)
2.5.3 China Prostate Cancer Diagnostics Estimates and Projections (2018-2029)
2.5.4 Japan Prostate Cancer Diagnostics Estimates and Projections (2018-2029)
2.5.5 Southeast Asia Prostate Cancer Diagnostics Estimates and Projections (2018-2029)
2.5.6 India Prostate Cancer Diagnostics Estimates and Projections (2018-2029)
3 Global Prostate Cancer Diagnostics Competition Landscape by Players
3.1 Global Top Prostate Cancer Diagnostics Players by Revenue (2018-2023)
3.1.1 Global Top Prostate Cancer Diagnostics Players by Revenue (2018-2023)
3.1.2 Global Prostate Cancer Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Prostate Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Diagnostics Revenue
3.4 Global Prostate Cancer Diagnostics Market Concentration Ratio
3.4.1 Global Prostate Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Diagnostics Revenue in 2022
3.5 Prostate Cancer Diagnostics Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Diagnostics Product Solution and Service
3.7 Date of Enter into Prostate Cancer Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Diagnostics Breakdown Data by Type
4.1 Global Prostate Cancer Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Prostate Cancer Diagnostics Forecasted Market Size by Type (2024-2029)
5 Prostate Cancer Diagnostics Breakdown Data by Application
5.1 Global Prostate Cancer Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Prostate Cancer Diagnostics Forecasted Market Size by Application (2024-2029)
6 United States Prostate Cancer Diagnostics Market Facts & Figures
6.1 United States Prostate Cancer Diagnostics Revenue by Company (2018-2023)
6.2 United States Prostate Cancer Diagnostics Market Size by Type
6.2.1 United States Prostate Cancer Diagnostics Market Size by Type (2018-2023)
6.2.2 United States Prostate Cancer Diagnostics Market Size by Type (2024-2029)
6.2.3 United States Prostate Cancer Diagnostics Market Share by Type (2018-2029)
6.3 United States Prostate Cancer Diagnostics Market Size by Application
6.3.1 United States Prostate Cancer Diagnostics Market Size by Application (2018-2023)
6.3.2 United States Prostate Cancer Diagnostics Market Size by Application (2024-2029)
6.3.3 United States Prostate Cancer Diagnostics Market Share by Application (2018-2029)
7 Europe Prostate Cancer Diagnostics Market Facts & Figures
7.1 Europe Prostate Cancer Diagnostics Revenue by Company (2018-2023)
7.2 Europe Prostate Cancer Diagnostics Market Size by Type
7.2.1 Europe Prostate Cancer Diagnostics Market Size by Type (2018-2023)
7.2.2 Europe Prostate Cancer Diagnostics Market Size by Type (2024-2029)
7.2.3 Europe Prostate Cancer Diagnostics Market Share by Type (2018-2029)
7.3 Europe Prostate Cancer Diagnostics Market Size by Application
7.3.1 Europe Prostate Cancer Diagnostics Market Size by Application (2018-2023)
7.3.2 Europe Prostate Cancer Diagnostics Market Size by Application (2024-2029)
7.3.3 Europe Prostate Cancer Diagnostics Market Share by Application (2018-2029)
8 China Prostate Cancer Diagnostics Market Facts & Figures
8.1 China Prostate Cancer Diagnostics Revenue by Company (2018-2023)
8.2 China Prostate Cancer Diagnostics Market Size by Type
8.2.1 China Prostate Cancer Diagnostics Market Size by Type (2018-2023)
8.2.2 China Prostate Cancer Diagnostics Market Size by Type (2024-2029)
8.2.3 China Prostate Cancer Diagnostics Market Share by Type (2018-2029)
8.3 China Prostate Cancer Diagnostics Market Size by Application
8.3.1 China Prostate Cancer Diagnostics Market Size by Application (2018-2023)
8.3.2 China Prostate Cancer Diagnostics Market Size by Application (2024-2029)
8.3.3 China Prostate Cancer Diagnostics Market Share by Application (2018-2029)
9 Japan Prostate Cancer Diagnostics Market Facts & Figures
9.1 Japan Prostate Cancer Diagnostics Revenue by Company (2018-2023)
9.2 Japan Prostate Cancer Diagnostics Market Size by Type
9.2.1 Japan Prostate Cancer Diagnostics Market Size by Type (2018-2023)
9.2.2 Japan Prostate Cancer Diagnostics Market Size by Type (2024-2029)
9.2.3 Japan Prostate Cancer Diagnostics Market Share by Type (2018-2029)
9.3 Japan Prostate Cancer Diagnostics Market Size by Application
9.3.1 Japan Prostate Cancer Diagnostics Market Size by Application (2018-2023)
9.3.2 Japan Prostate Cancer Diagnostics Market Size by Application (2024-2029)
9.3.3 Japan Prostate Cancer Diagnostics Market Share by Application (2018-2029)
10 Southeast Asia Prostate Cancer Diagnostics Market Facts & Figures
10.1 Southeast Asia Prostate Cancer Diagnostics Revenue by Company (2018-2023)
10.2 Southeast Asia Prostate Cancer Diagnostics Market Size by Type
10.2.1 Southeast Asia Prostate Cancer Diagnostics Market Size by Type (2018-2023)
10.2.2 Southeast Asia Prostate Cancer Diagnostics Market Size by Type (2024-2029)
10.2.3 Southeast Asia Prostate Cancer Diagnostics Market Share by Type (2018-2029)
10.3 Southeast Asia Prostate Cancer Diagnostics Market Size by Application
10.3.1 Southeast Asia Prostate Cancer Diagnostics Market Size by Application (2018-2023)
10.3.2 Southeast Asia Prostate Cancer Diagnostics Market Size by Application (2024-2029)
10.3.3 Southeast Asia Prostate Cancer Diagnostics Market Share by Application (2018-2029)
11 India Prostate Cancer Diagnostics Market Facts & Figures
11.1 India Prostate Cancer Diagnostics Revenue by Company (2018-2023)
11.2 India Prostate Cancer Diagnostics Market Size by Type
11.2.1 India Prostate Cancer Diagnostics Market Size by Type (2018-2023)
11.2.2 India Prostate Cancer Diagnostics Market Size by Type (2024-2029)
11.2.3 India Prostate Cancer Diagnostics Market Share by Type (2018-2029)
11.3 India Prostate Cancer Diagnostics Market Size by Application
11.3.1 India Prostate Cancer Diagnostics Market Size by Application (2018-2023)
11.3.2 India Prostate Cancer Diagnostics Market Size by Application (2024-2029)
11.3.3 India Prostate Cancer Diagnostics Market Share by Application (2018-2029)
12 Key Players Profiles
12.1 OPKO
12.1.1 OPKO Company Details
12.1.2 OPKO Business Overview
12.1.3 OPKO Prostate Cancer Diagnostics Introduction
12.1.4 OPKO Revenue in Prostate Cancer Diagnostics Business (2018-2023)
12.1.5 OPKO Recent Development
12.2 Genomic Health
12.2.1 Genomic Health Company Details
12.2.2 Genomic Health Business Overview
12.2.3 Genomic Health Prostate Cancer Diagnostics Introduction
12.2.4 Genomic Health Revenue in Prostate Cancer Diagnostics Business (2018-2023)
12.2.5 Genomic Health Recent Development
12.3 Abbott
12.3.1 Abbott Company Details
12.3.2 Abbott Business Overview
12.3.3 Abbott Prostate Cancer Diagnostics Introduction
12.3.4 Abbott Revenue in Prostate Cancer Diagnostics Business (2018-2023)
12.3.5 Abbott Recent Development
12.4 Beckman Coulter
12.4.1 Beckman Coulter Company Details
12.4.2 Beckman Coulter Business Overview
12.4.3 Beckman Coulter Prostate Cancer Diagnostics Introduction
12.4.4 Beckman Coulter Revenue in Prostate Cancer Diagnostics Business (2018-2023)
12.4.5 Beckman Coulter Recent Development
12.5 Siemens Healthcare
12.5.1 Siemens Healthcare Company Details
12.5.2 Siemens Healthcare Business Overview
12.5.3 Siemens Healthcare Prostate Cancer Diagnostics Introduction
12.5.4 Siemens Healthcare Revenue in Prostate Cancer Diagnostics Business (2018-2023)
12.5.5 Siemens Healthcare Recent Development
12.6 bioMeriux
12.6.1 bioMeriux Company Details
12.6.2 bioMeriux Business Overview
12.6.3 bioMeriux Prostate Cancer Diagnostics Introduction
12.6.4 bioMeriux Revenue in Prostate Cancer Diagnostics Business (2018-2023)
12.6.5 bioMeriux Recent Development
12.7 Roche
12.7.1 Roche Company Details
12.7.2 Roche Business Overview
12.7.3 Roche Prostate Cancer Diagnostics Introduction
12.7.4 Roche Revenue in Prostate Cancer Diagnostics Business (2018-2023)
12.7.5 Roche Recent Development
12.8 MDx Health
12.8.1 MDx Health Company Details
12.8.2 MDx Health Business Overview
12.8.3 MDx Health Prostate Cancer Diagnostics Introduction
12.8.4 MDx Health Revenue in Prostate Cancer Diagnostics Business (2018-2023)
12.8.5 MDx Health Recent Development
12.9 DiaSorin
12.9.1 DiaSorin Company Details
12.9.2 DiaSorin Business Overview
12.9.3 DiaSorin Prostate Cancer Diagnostics Introduction
12.9.4 DiaSorin Revenue in Prostate Cancer Diagnostics Business (2018-2023)
12.9.5 DiaSorin Recent Development
12.10 Myriad Genetics
12.10.1 Myriad Genetics Company Details
12.10.2 Myriad Genetics Business Overview
12.10.3 Myriad Genetics Prostate Cancer Diagnostics Introduction
12.10.4 Myriad Genetics Revenue in Prostate Cancer Diagnostics Business (2018-2023)
12.10.5 Myriad Genetics Recent Development
12.11 Ambry Genetics
12.11.1 Ambry Genetics Company Details
12.11.2 Ambry Genetics Business Overview
12.11.3 Ambry Genetics Prostate Cancer Diagnostics Introduction
12.11.4 Ambry Genetics Revenue in Prostate Cancer Diagnostics Business (2018-2023)
12.11.5 Ambry Genetics Recent Development
13 Market Dynamics
13.1 Prostate Cancer Diagnostics Industry Trends
13.2 Prostate Cancer Diagnostics Market Drivers
13.3 Prostate Cancer Diagnostics Market Challenges
13.4 Prostate Cancer Diagnostics Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author List
15.3 Disclaimer
List of TablesTable 1. Global Prostate Cancer Diagnostics Market Size Growth Rate by Type (US$ Million): (2018 VS 2022 VS 2029)
Table 2. Major Players of Tumor Biomarker Tests
Table 3. Major Players of Imaging
Table 4. Key Players of Biopsy
Table 5. Key Players of Other
Table 6. Global Prostate Cancer Diagnostics Market Size Growth by Application (2018 VS 2022 VS 2029)
Table 7. Global Prostate Cancer Diagnostics Market Size (US$ Million) by Region: 2018 VS 2022 VS 2029
Table 8. Global Prostate Cancer Diagnostics Revenue (US$ Million) Market Share by Region (2018-2023))
Table 9. Global Prostate Cancer Diagnostics Revenue Share by Region (2018-2023)
Table 10. Global Prostate Cancer Diagnostics Revenue (US$ Million) Forecast by Region (2024-2029)
Table 11. Global Prostate Cancer Diagnostics Revenue Share Forecast by Region (2024-2029)
Table 12. Global Prostate Cancer Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 13. Global Prostate Cancer Diagnostics Revenue Share by Players (2018-2023)
Table 14. Global Prostate Cancer Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Diagnostics as of 2022)
Table 15. Ranking of Global Top Prostate Cancer Diagnostics Companies by Revenue (US$ Million) in 2021
Table 16. Global 5 Largest Players Market Share by Prostate Cancer Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 17. Key Players Headquarters and Area Served
Table 18. Key Players Prostate Cancer Diagnostics Product Solution and Service
Table 19. Date of Enter into Prostate Cancer Diagnostics Market
Table 20. Mergers & Acquisitions, Expansion Plans
Table 21. Global Prostate Cancer Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 22. Global Prostate Cancer Diagnostics Revenue Market Share by Type (2018-2023)
Table 23. Global Prostate Cancer Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 24. Global Prostate Cancer Diagnostics Revenue Market Share by Type (2024-2029)
Table 25. Global Prostate Cancer Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 26. Global Prostate Cancer Diagnostics Revenue Market Share by Application (2018-2023)
Table 27. Global Prostate Cancer Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 28. Global Prostate Cancer Diagnostics Revenue Market Share by Application (2024-2029)
Table 29. United States Prostate Cancer Diagnostics Revenue by Company (2018-2023) & (US$ Million)
Table 30. United States Prostate Cancer Diagnostics Revenue Market Share by Company (2018-2023)
Table 31. United States Prostate Cancer Diagnostics Market Size by Type (2018-2023) & (K Units)
Table 32. United States Prostate Cancer Diagnostics Market Size by Type (2024-2029) & (K Units)
Table 33. United States Prostate Cancer Diagnostics Market Size by Application (2018-2023) & (K Units)
Table 34. United States Prostate Cancer Diagnostics Market Size by Application (2024-2029) & (K Units)
Table 35. Europe Prostate Cancer Diagnostics Revenue by Company (2018-2023) & (US$ Million)
Table 36. Europe Prostate Cancer Diagnostics Revenue Market Share by Company (2018-2023)
Table 37. Europe Prostate Cancer Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 38. Europe Prostate Cancer Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 39. Europe Prostate Cancer Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 40. Europe Prostate Cancer Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 41. China Prostate Cancer Diagnostics Revenue by Company (2018-2023) & (US$ Million)
Table 42. China Prostate Cancer Diagnostics Revenue Market Share by Company (2018-2023)
Table 43. China Prostate Cancer Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 44. China Prostate Cancer Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 45. China Prostate Cancer Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 46. China Prostate Cancer Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 47. Japan Prostate Cancer Diagnostics Revenue by Company (2018-2023) & (US$ Million)
Table 48. Japan Prostate Cancer Diagnostics Revenue Market Share by Company (2018-2023)
Table 49. Japan Prostate Cancer Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 50. Japan Prostate Cancer Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 51. Japan Prostate Cancer Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 52. Japan Prostate Cancer Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 53. Southeast Asia Prostate Cancer Diagnostics Revenue by Company (2018-2023) & (US$ Million)
Table 54. Southeast Asia Prostate Cancer Diagnostics Revenue Market Share by Company (2018-2023)
Table 55. Southeast Asia Prostate Cancer Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 56. Southeast Asia Prostate Cancer Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 57. Southeast Asia Prostate Cancer Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 58. Southeast Asia Prostate Cancer Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 59. India Prostate Cancer Diagnostics Revenue by Company (2018-2023) & (US$ Million)
Table 60. India Prostate Cancer Diagnostics Revenue Market Share by Company (2018-2023)
Table 61. India Prostate Cancer Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 62. India Prostate Cancer Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 63. India Prostate Cancer Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 64. India Prostate Cancer Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 65. OPKO Company Details
Table 66. OPKO Description and Business Overview
Table 67. OPKO Prostate Cancer Diagnostics Product
Table 68. OPKO Revenue in Prostate Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 69. OPKO Recent Development
Table 70. Genomic Health Company Details
Table 71. Genomic Health Description and Business Overview
Table 72. Genomic Health Prostate Cancer Diagnostics Product
Table 73. Genomic Health Revenue in Prostate Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 74. Genomic Health Recent Development
Table 75. Abbott Company Details
Table 76. Abbott Description and Business Overview
Table 77. Abbott Prostate Cancer Diagnostics Product
Table 78. Abbott Revenue in Prostate Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 79. Abbott Recent Development
Table 80. Beckman Coulter Company Details
Table 81. Beckman Coulter Description and Business Overview
Table 82. Beckman Coulter Prostate Cancer Diagnostics Product
Table 83. Beckman Coulter Revenue in Prostate Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 84. Beckman Coulter Recent Development
Table 85. Siemens Healthcare Company Details
Table 86. Siemens Healthcare Description and Business Overview
Table 87. Siemens Healthcare Prostate Cancer Diagnostics Product
Table 88. Siemens Healthcare Revenue in Prostate Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 89. Siemens Healthcare Recent Development
Table 90. bioMeriux Company Details
Table 91. bioMeriux Description and Business Overview
Table 92. bioMeriux Prostate Cancer Diagnostics Product
Table 93. bioMeriux Revenue in Prostate Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 94. bioMeriux Recent Development
Table 95. Roche Company Details
Table 96. Roche Description and Business Overview
Table 97. Roche Prostate Cancer Diagnostics Product
Table 98. Roche Revenue in Prostate Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 99. Roche Recent Development
Table 100. MDx Health Company Details
Table 101. MDx Health Prostate Cancer Diagnostics Product
Table 102. MDx Health Description and Business Overview
Table 103. MDx Health Revenue in Prostate Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 104. MDx Health Recent Development
Table 105. DiaSorin Company Details
Table 106. DiaSorin Prostate Cancer Diagnostics Product
Table 107. DiaSorin Description and Business Overview
Table 108. DiaSorin Revenue in Prostate Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 109. DiaSorin Recent Development
Table 110. Myriad Genetics Company Details
Table 111. Myriad Genetics Description and Business Overview
Table 112. Myriad Genetics Prostate Cancer Diagnostics Product
Table 113. Myriad Genetics Revenue in Prostate Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 114. Myriad Genetics Recent Development
Table 115. Ambry Genetics Company Details
Table 116. Ambry Genetics Description and Business Overview
Table 117. Ambry Genetics Prostate Cancer Diagnostics Product
Table 118. Ambry Genetics Revenue in Prostate Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 119. Ambry Genetics Recent Development
Table 120. Prostate Cancer Diagnostics Market Trends
Table 121. Prostate Cancer Diagnostics Market Drivers
Table 122. Prostate Cancer Diagnostics Market Challenges
Table 123. Prostate Cancer Diagnostics Market Restraints
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Prostate Cancer Diagnostics Market Share by Type: 2022 VS 2029
Figure 2. Tumor Biomarker Tests Features
Figure 3. Imaging Features
Figure 4. Biopsy Features
Figure 5. Other Features
Figure 6. Global Prostate Cancer Diagnostics Market Share by Application: 2022 VS 2029
Figure 7. Age Below 55 Case Studies
Figure 8. Age 55-75 Case Studies
Figure 9. Age Above 75 Case Studies
Figure 10. Prostate Cancer Diagnostics Report Years Considered
Figure 11. Global Prostate Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Prostate Cancer Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Prostate Cancer Diagnostics Revenue Market Share by Region: 2018 VS 2022
Figure 14. United States Prostate Cancer Diagnostics Revenue (Million USD) Growth Rate (2018-2029)
Figure 15. Europe Prostate Cancer Diagnostics Revenue (Million USD) Growth Rate (2018-2029)
Figure 16. China Prostate Cancer Diagnostics Revenue (Million USD) Growth Rate (2018-2029)
Figure 17. Japan Prostate Cancer Diagnostics Revenue (Million USD) Growth Rate (2018-2029)
Figure 18. Southeast Asia Prostate Cancer Diagnostics Revenue (Million USD) Growth Rate (2018-2029)
Figure 19. India Prostate Cancer Diagnostics Revenue (Million USD) Growth Rate (2018-2029)
Figure 20. Global Prostate Cancer Diagnostics Market Share by Players in 2022
Figure 21. Global Top Prostate Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnostics as of 2022)
Figure 22. The Top 10 and 5 Players Market Share by Prostate Cancer Diagnostics Revenue in 2022
Figure 23. United States Prostate Cancer Diagnostics Market Share by Type (2018-2029)
Figure 24. United States Prostate Cancer Diagnostics Market Share by Application (2018-2029)
Figure 25. Europe Prostate Cancer Diagnostics Market Share by Type (2018-2029)
Figure 26. Europe Prostate Cancer Diagnostics Market Share by Application (2018-2029)
Figure 27. China Prostate Cancer Diagnostics Market Share by Type (2018-2029)
Figure 28. China Prostate Cancer Diagnostics Market Share by Application (2018-2029)
Figure 29. Japan Prostate Cancer Diagnostics Market Share by Type (2018-2029)
Figure 30. Japan Prostate Cancer Diagnostics Market Share by Application (2018-2029)
Figure 31. Southeast Asia Prostate Cancer Diagnostics Market Share by Type (2018-2029)
Figure 32. Southeast Asia Prostate Cancer Diagnostics Market Share by Application (2018-2029)
Figure 33. India Prostate Cancer Diagnostics Market Share by Type (2018-2029)
Figure 34. India Prostate Cancer Diagnostics Market Share by Application (2018-2029)
Figure 35. OPKO Revenue Growth Rate in Prostate Cancer Diagnostics Business (2018-2023)
Figure 36. Genomic Health Revenue Growth Rate in Prostate Cancer Diagnostics Business (2018-2023)
Figure 37. Abbott Revenue Growth Rate in Prostate Cancer Diagnostics Business (2018-2023)
Figure 38. Beckman Coulter Revenue Growth Rate in Prostate Cancer Diagnostics Business (2018-2023)
Figure 39. Siemens Healthcare Revenue Growth Rate in Prostate Cancer Diagnostics Business (2018-2023)
Figure 40. bioMeriux Revenue Growth Rate in Prostate Cancer Diagnostics Business (2018-2023)
Figure 41. Roche Revenue Growth Rate in Prostate Cancer Diagnostics Business (2018-2023)
Figure 42. MDx Health Revenue Growth Rate in Prostate Cancer Diagnostics Business (2018-2023)
Figure 43. DiaSorin Revenue Growth Rate in Prostate Cancer Diagnostics Business (2018-2023)
Figure 44. Myriad Genetics Revenue Growth Rate in Prostate Cancer Diagnostics Business (2018-2023)
Figure 45. Ambry Genetics Revenue Growth Rate in Prostate Cancer Diagnostics Business (2018-2023)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed